Critically, Nrf2 deficiency or pharmacological inhibition abolishes this protection and worsens COPD pathology, underscoring the crucial role of the Nrf2/HO-1 axis [28]. This evidence concerns the gene HMOX1 and chronic obstructive pulmonary disease.